Company
Headquarters: Indore, India
Employees: 98
₹170.0 Million
INR as of Sept. 1, 2021
US$2.3 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Syncom Healthcare Limited engages in the manufacture and marketing of pharmaceutical formulations in India and internationally. It also offers nutraceutical products and ayurvedic formulations. The company was incorporated in 2002 and is based in Indore, India. Syncom Healthcare Limited is in corporate insolvency resolution process under the provisions of Section 7 of the Insolvency and Bankruptcy Code, 2016.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Syncom Healthcare Ltd has the following listings and related stock indices.
Stock: NSE: SYNCOM wb_incandescent